The latest report by IMARC Group, titled “Large Volume Parenteral (LVP) Market Report by Type (Soft Bag LVP, Plastic Bottle LVP, Glass Bottle LVP), Volume (100 ML - 250 ML, 250 ML - 500 ML, 500 ML - 1000 ML, 1000 ML - 2000 ML, 2000 ML and More), Application (Therapeutic Injections, Fluid Balance Injections, Nutritious Injections), End Users (Hospitals, Clinics, and Others), and Region 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on the market. The global large volume parenteral market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.

Factors Affecting the Growth of Large Volume Parenteral (LVP) Industry:

• Increasing Prevalence of Chronic Diseases:

The large volume parenteral (LVP) market is witnessing significant growth driven by the rising prevalence of chronic diseases worldwide. Chronic diseases, such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders, require long-term treatment often involving intravenous administration of medications or fluids. As the global population ages and lifestyles become increasingly sedentary, the incidence of chronic diseases is on the rise. This demographic shift has fueled the demand for LVP products, which are essential for the delivery of large volumes of fluids, electrolytes, and medications to patients.

• Significant Technological Advancements in Drug Delivery Systems

Technological advancements in drug delivery systems are playing a pivotal role in driving the growth of the large volume parenteral (LVP) market. As pharmaceutical companies invest in research and development to enhance the efficacy, safety, and convenience of drug administration, new and innovative LVP products are being introduced to the market. One significant technological advancement contributing to market growth is the development of advanced infusion pumps and infusion sets. These devices enable precise control over the administration rate and dosage of parenteral medications and fluids, enhancing patient safety and treatment outcomes. Furthermore, the integration of smart technology and connectivity features in infusion pumps allows for remote monitoring and real-time data transmission, facilitating more efficient and personalized patient care.

• Rising Demand for Home Healthcare Services:

The rising demand for home healthcare services is a significant factor driving the growth of the large volume parenteral (LVP) market. As healthcare delivery models evolve to meet the changing needs and preferences of patients, there is increasing emphasis on providing medical care in the comfort and convenience of patients' homes. This shift toward home-based care is driven by various factors, including demographic changes, technological advancements, and efforts to contain healthcare costs. One key driver of the growing demand for home healthcare services is the aging population. With a larger proportion of the population entering old age, there is a greater prevalence of chronic diseases and age-related conditions that require ongoing medical management.

For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/large-volume-parenteral-market/requestsample

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

• Albert David Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• BML Parenteral Drugs
• Fresenius Kabi AG
• Grifols S.A
• Otsuka Pharmaceutical Co. Ltd
• Pharmaceutical Solutions Industry Ltd.
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Thermo Fisher Scientific Inc.

Large Volume Parenteral (LVP) Market Report Segmentation:

By Type:

• Soft Bag LVP
• Plastic Bottle LVP
• Glass Bottle LVP

Soft bag LVP dominates the market due to its flexibility, ease of handling, and compatibility with a wide range of medications, making it a preferred choice for intravenous administration in various healthcare settings.

By Volume:

• 100 ML - 250 ML
• 250 ML - 500 ML
• 500 ML - 1000 ML
• 1000 ML - 2000 ML
• 2000 ML and More

500 ML-1000 ML holds maximum number of shares due to its versatility in catering to a wide range of therapeutic applications and patient needs, spanning from hydration therapy to the administration of medications and fluids in various healthcare settings.

By Application:

• Therapeutic Injections
• Fluid Balance Injections
• Nutritious Injections

Nutritious injections represent the largest segment due to the increasing prevalence of malnutrition, chronic diseases, and the growing demand for specialized parenteral nutrition formulations to support patient health and recovery.

By End Users:

• Hospitals
• Clinics
• Others

Based on the end user, the market has been divided into hospitals, clinics, and others.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the large volume parenteral (LVP) market is attributed to factors such as well-established healthcare infrastructure, high adoption of advanced medical technologies, and significant investment in research and development by pharmaceutical companies.

Global Large Volume Parenteral (LVP) Market Trends:

The rising healthcare expenditure in North America, driven by factors such as increasing healthcare demand, technological advancements, and the prevalence of chronic diseases, is fueling the growth of the LVP market. Governments, private healthcare providers, and insurance companies are allocating substantial resources to enhance healthcare infrastructure, expand access to medical services, and improve patient outcomes. As a result, there is growing investment in intravenous therapies and parenteral nutrition solutions, driving the demand for LVP products across various healthcare settings, including hospitals, clinics, and ambulatory care centers.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=reportid=5711flag=C

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163